Solvay invests in Suanfarma to boost natural vanillin growth
The Group will further develop its capabilities to develop natural ingredients for food, flavors and fragrance markets.
Solvay announces an investment in Suanfarma’s Cipan manufacturing site located in Lisbon, Portugal to develop its biotechnological capabilities and support the development of natural ingredients. This transaction, to be completed by mid-2023, is the first step of a long-term strategic alliance with Suanfarma, held by ArchiMed, a leading global life science investment firm. It will enable Solvay to grow its capabilities for natural ingredients in Food, Flavors & Fragrances industries.
“Solvay is already a leader in natural ingredients - now with this exciting investment we will pave the way for further growth in Naturals. The investment is in line with our newly formed Renewable Materials and Biotechnology growth platform, and will boost our ability to meet our customers' long-term needs and enable the switch to bio-sourced and natural ingredients,” said An Nuyttens, Aroma & Silica Global Business Units President.
“This first step of our collaboration with Suanfarma provides access to efficiently raise our existing capacities on natural ingredients, including our flagship natural vanillin, Rhovanil® Natural CW. Produced through a natural fermentation process with the highest standards of quality control and traceability, Rhovanil® Natural is manufactured in Europe and offers reliable and future-proof supply to our customers,” added Jo Grosemans, Solvay Natural Growth Director.
Solvay is committed to playing an important role in sustaining the world’s ever-increasing demand for food by reducing environmental impact and resource consumption while meeting consumer desires for healthier, safer, tastier, and more natural foods. This aligns with Solvay’s newest growth platform “Renewable materials and biotechnology” which aims to meet growing demand for sustainable solutions by increasing the share of renewable carbon in Solvay’s product offering and developing new business opportunities enabled by biotechnology
Solvay is a science company whose technologies bring benefits to many aspects of daily life. With more than 21,000 employees in 63 countries, Solvay bonds people, ideas and elements to reinvent progress. The Group seeks to create sustainable shared value for all, notably through its Solvay One Planet roadmap crafted around three pillars: protecting the climate, preserving resources and fostering a better life. The Group’s innovative solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices, health care applications, water and air purification systems. Founded in 1863, Solvay today ranks among the world’s top three companies for the vast majority of its activities and delivered net sales of €10.1 billion in 2021. Solvay is listed on Euronext Brussels and Paris (SOLB). Learn more at www.solvay.com.